BriaCell Therapeutics Corp. (CVE:BCT – Get Free Report) traded down 3.8% on Monday . The company traded as low as C$10.60 and last traded at C$10.60. 3,402 shares traded hands during mid-day trading, ...
BriaCell Therapeutics (TSE:BCT) has released an update.Don't Miss Our New Year's Offers:Discover the latest stocks recommended by top Wall ...
BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by ...
PHILADELPHIA and VANCOUVER, British Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops no ...
BriaCell Therapeutics shares are trading lower by 40% Thursday afternoon. The company announced the pricing of a $5.5 million public offering. Discover Fast-Growing Stocks Every Month BriaCell ...
BriaCell Therapeutics Corp. PHILADELPHIA and Vancouver, British Columbia, Dec. 11, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the ...
PHILADELPHIA and VANCOUVER, British Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the ...